LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
26.01
+0.30 (1.17%)
At close: Apr 1, 2025, 4:00 PM
28.24
+2.23 (8.58%)
After-hours: Apr 1, 2025, 4:53 PM EDT
LENZ Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$38.00
Upside
+46.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $44 → $47 | Strong Buy | Maintains | $44 → $47 | +80.70% | Mar 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +46.10% | Nov 7, 2024 |
| Raymond James | Raymond James | Buy Initiates $37 | Buy | Initiates | $37 | +42.25% | Sep 27, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $36 | Buy | Maintains | $36 | +38.41% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +46.10% | Aug 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +46.10% | Aug 12, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $32 | Buy | Initiates | $32 | +23.03% | Apr 15, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 15, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $34 | Strong Buy | Initiates | $34 | +30.72% | Apr 10, 2024 |
| Piper Sandler | Piper Sandler | Buy Initiates $28 | Buy | Initiates | $28 | +7.65% | Mar 27, 2024 |